Sg3 Management, LLC Immuno Gen, Inc. Call Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $272,160 - $497,664	-86,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.26 - $7.48 $368,064 - $646,272	86,400 New	86,400 $411,000
Q4 2021 Feb 15, 2022	SELL	$4.75 - $7.5 $159,125 - $251,250	-33,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $444,269 - $583,215	-88,500 Reduced 72.54%	33,500 $190,000
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $127,380 - $189,200	22,000 Added 22.0%	122,000 $804,000
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $370,000 - $766,000	100,000 New	100,000 $645,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.